Volume 21 Issue 12
Dec.  2023
Turn off MathJax
Article Contents
SHAO Xiaoxiao, SHI Ruixin, FANG Ye, WANG Weizhong, JIANG Yi. Ustekinumab in the treatment of stenosis Crohn's disease: A case report and literature review[J]. Chinese Journal of General Practice, 2023, 21(12): 2169-2172. doi: 10.16766/j.cnki.issn.1674-4152.003315
Citation: SHAO Xiaoxiao, SHI Ruixin, FANG Ye, WANG Weizhong, JIANG Yi. Ustekinumab in the treatment of stenosis Crohn's disease: A case report and literature review[J]. Chinese Journal of General Practice, 2023, 21(12): 2169-2172. doi: 10.16766/j.cnki.issn.1674-4152.003315

Ustekinumab in the treatment of stenosis Crohn's disease: A case report and literature review

doi: 10.16766/j.cnki.issn.1674-4152.003315
Funds:

 Y2020285

 19331101

  • Received Date: 2023-03-28
    Available Online: 2024-01-29
  • Crohn's disease (CD) is a chronic granulomatous disease of unknown etiology that can affect any part of the alimentary tract from the mouth to the anus. CD is often accompanied by a variety of complications, such as intestinal lumen stenosis, intestinal fistula, abscess and perforation. Intestinal lumen stenosis is the most common complication, and there is still a lack of effective methods for the radical treatment of CD intestinal lumen stenosis. Recent studies have found that ustekinumab (UST) attenuates chronic inflammation-associated stenosis in the intestinal tract of CD patients by inhibiting IL-12 and IL-23-mediated cell signaling, activation, and downstream inflammatory cytokine production. In this paper, a case of CD complicated with intestinal stenosis admitted to the Second Affiliated Hospital of Wenzhou Medical University was treated with UST and achieved good therapeutic effect. The case is reported as follows and relevant literature is reviewed.

     

  • loading
  • [1]
    CHAN W P W, MOURAD F, LEONG R W. Crohn's disease associated strictures[J]. J Gastroenterol Hepatol, 2018, 33(5): 998-1008. doi: 10.1111/jgh.14119
    [2]
    宋彩霞, 马强. 小肠疾病的临床特点及研究现状[J]. 中国临床研究, 2018, 31(3): 424-426.

    SONG C R, MA Q. The clinical features and research status of small intestinal diseases[J]. Chinese Journal of Clinical Research, 2018, 31(3): 424-426.
    [3]
    刁磊, 洪汝涛, 韩玮, 等. CT小肠成像与双气囊小肠镜在疑似小肠出血诊断中的临床应用[J]. 中华全科医学, 2021, 19(8): 1347-1350. doi: 10.16766/j.cnki.issn.1674-4152.002057

    DIAO L, HONG R T, HAN W, et al. Clinical application of CT enterography and double-balloon enteroscopy in the diagnosis of suspected small intestinal bleeding[J]. Chinese Journal of General Practice, 2021, 19(8): 1347-1350. doi: 10.16766/j.cnki.issn.1674-4152.002057
    [4]
    VEAUTHIER B, HORNECKER J R. Crohn's disease: diagnosis and management[J]. Am Fam Physician, 2018, 98(11): 661-669.
    [5]
    LI J, MAO R, KURADA S, et al. Pathogenesis of fibrostenosing Crohn's disease[J]. Transl Res, 2019, 209(7): 39-54.
    [6]
    LIN X X, QIU Y, ZHUANG X J, et al. Intestinal stricture in Crohn's disease: a 2020 update[J]. J Dig Dis, 2021, 22(7): 390-398. doi: 10.1111/1751-2980.13022
    [7]
    WANG J, LIN S, BROWN JM, et al. Novel mechanisms and clinical trial endpoints in intestinal fibrosis[J]. Immunol Rev, 2021, 302(1): 211-227. doi: 10.1111/imr.12974
    [8]
    MA C, JAIRATH V, CLICK B, et al. Targeting anti-fibrotic pathways in Crohn's disease: the final frontier?[J]. Best Pract Res Clin Gastroenterol, 2019, 38-39(1): 101603. DOI: 10.1016/j.bpg.2019.02.005.
    [9]
    ALFREDSSON J, WICK M J. Mechanism of fibrosis and stricture formation in Crohn's disease[J]. Scand J Immunol, 2020, 92(6): e12990. DOI: 10.1111/sji.12990
    [10]
    YOO J H, HOLUBAR S, RIEDER F. Fibrostenotic strictures in Crohn's disease[J]. Intest Res, 2020, 18(4): 379-401. doi: 10.5217/ir.2019.09148
    [11]
    王革非. 克罗恩病并发肠梗阻的诊断与治疗[J]. 肠外与肠内营养, 2019, 26(1): 1-5.

    WANG G F. Diagnosis and treatment of Crohn's disease complicated with intestinal obstruction[J]. Parenteral & Enteral Nutrition, 2019, 26(1): 1-5.
    [12]
    时雯琳, 金世柱, 王丽霞, 等. 内镜下克罗恩病合并肠道狭窄治疗研究[J]. 胃肠病学和肝病学杂志, 2019, 28(8): 853-856.

    SHI W L, JIN S Z, WANG L X, et al. Study of endoscopic treatment of Crohn's disease with intestinal stenosis[J]. Chinese Journal of Gastroenterology and Hepatology, 2019, 28(8): 853-856.
    [13]
    HONAP S, MEADE S, IBRAHEIM H, et al. Effectiveness and safety of ustekinumab in inflammatory bowel disease: a systematic review and meta-analysis[J]. Dig Dis Sci, 2022, 67(3): 1018-1035. doi: 10.1007/s10620-021-06932-4
    [14]
    AGGELETOPOULOU I, ASSIMAKOPOULOS S F, KONSTANTAKIS C, et al. Interleukin 12/interleukin 23 pathway: biological basis and therapeutic effect in patients with Crohn's disease[J]. World J Gastroenterol, 2018, 24(36): 4093-4103. doi: 10.3748/wjg.v24.i36.4093
    [15]
    PETAGNA L, ANTONELLI A, GANINI C, et al. Pathophysiology of Crohn's disease inflammation and recurrence[J]. Biol Direct, 2020, 15(1): 23. doi: 10.1186/s13062-020-00280-5
    [16]
    WEISSHOF R, EL JURDI K, ZMETER N, et al. Emerging therapies for inflammatory bowel disease[J]. Adv Ther, 2018, 35(11): 1746-1762. doi: 10.1007/s12325-018-0795-9
    [17]
    MURATE K, NAKAMURA M, YAMAMURA T, et al. Ustekinumab is effective against small bowel lesions in Crohn's disease: two case reports[J]. Clin J Gastroenterol, 2021, 14(1): 129-135. doi: 10.1007/s12328-020-01242-0
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(3)

    Article Metrics

    Article views (281) PDF downloads(21) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return